Variable | r | |
---|---|---|
6MWD | TUG | |
General | ||
Sex | 0.21 | −0.06 |
Age, yrs | −0.16 | 0.28* |
Weight | −0.02 | 0.17 |
Height | 0.29* | 0.01 |
BMI | −0.27* | 0.30* |
No. cigarettes daily† | −0.28 | 0.13 |
Physical activity ≥ 2–3 h/week | 0.21 | −0.16 |
Physical activity frequency ≥ 2–3×/week | 0.23 | −0.14 |
SF-36 PCS | 0.64*** | −0.69*** |
Disease-specific variables | ||
ESR | −0.37** | 0.35** |
CK† | 0.25 | −0.23 |
Inactive disease PRINTO | 0.37** | −0.29* |
Disease duration | −0.12 | 0.25 |
Diagnosis before/after 1990 | 0.02 | 0.08 |
Use of prednisolone or DMARD | −0.26 | 0.11 |
Cum prednisolone dose† | −0.17 | 0.24 |
DAS total | −0.33* | 0.32* |
DAS muscle† | −0.45*** | 0.47*** |
DAS skin | −0.03 | −0.04 |
MyoAct† | −0.35** | 0.32* |
MITAX† | −0.24 | 0.33* |
Calcinosis | 0.11 | 0.09 |
Joint contractures | −0.05 | 0.27* |
MDI total | −0.19 | 0.31* |
CHAQ/HAQ† | −0.42** | 0.39** |
Muscle | ||
MMT† | 0.41** | −0.30* |
CMAS† | 0.58*** | −0.51*** |
MRI thigh pathology | −0.26 | 0.29* |
Lung | ||
Low DLCO | −0.28* | −0.18 |
Low TLC | −0.02 | −0.20 |
Low FVC | −0.30* | 0.38** |
HRCT pathology | −0.33* | 0.41** |
Heart | ||
Long axis strain | 0.00 | −0.19 |
E/É | −0.18 | 0.16 |
ECG pathology | 0.27* | −0.08 |
Systolic blood pressure | −0.16 | 0.22 |
Diastolic blood pressure | −0.25 | 0.35** |
↵* p < 0.05.
↵** p < 0.01.
↵*** p < 0.001.
↵† Spearman ρ. 6MWD: 6-min walk distance; TUG: timed up and go; BMI: body mass index; SF-36 PCS: Medical Outcomes Study Short Form-36 physical component summary; ESR: erythrocyte sedimentation rate; CK: creatinine kinase; PRINTO: Pediatric Rheumatology International Trials Organization; DMARD: disease-modifying antirheumatic drugs; DAS: Disease Activity Score; MyoAct: Myositis Disease Activity Assessment Visual Analogue scales; MITAX: Myositis Intention to Treat Activity Index; MDI: Myositis Damage Index; CHAQ/HAQ: child/adult Health Assessment Questionnaire; MMT: unilateral manual muscle test; CMAS: Childhood Myositis Assessment Score; MRI: magnetic resonance imaging; TLC: total lung capacity; FVC: forced vital capacity; HRCT: high-resolution computed tomography; E/É: early diastolic transmitral flow/early diastolic tissue velocity; ECG: electrocardiography; Low DLCOc/TLC/FVC: percentage predicted less than the fifth percentile of DLCO, corrected for hemoglobin, TLC, or FVC.